A detailed history of Red Spruce Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Red Spruce Capital, LLC holds 2,287 shares of LLY stock, worth $1.82 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
2,287
Previous 2,365 3.3%
Holding current value
$1.82 Million
Previous $2.14 Million 5.37%
% of portfolio
0.95%
Previous 1.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $60,226 - $74,881
-78 Reduced 3.3%
2,287 $2.03 Million
Q2 2024

Jul 02, 2024

SELL
$724.87 - $909.04 $18,846 - $23,635
-26 Reduced 1.09%
2,365 $2.14 Million
Q1 2024

Apr 10, 2024

SELL
$592.2 - $792.28 $416,316 - $556,972
-703 Reduced 22.72%
2,391 $1.86 Million
Q4 2023

Jan 05, 2024

SELL
$525.19 - $619.13 $52,519 - $61,913
-100 Reduced 3.13%
3,094 $1.8 Million
Q3 2023

Oct 03, 2023

SELL
$434.7 - $599.3 $104,328 - $143,832
-240 Reduced 6.99%
3,194 $1.72 Million
Q2 2023

Jul 05, 2023

SELL
$350.74 - $468.98 $11,574 - $15,476
-33 Reduced 0.95%
3,434 $1.61 Million
Q1 2023

Apr 06, 2023

SELL
$310.63 - $364.82 $36,343 - $42,683
-117 Reduced 3.26%
3,467 $1.19 Million
Q4 2022

Jan 03, 2023

BUY
$321.55 - $374.67 $1,286 - $1,498
4 Added 0.11%
3,584 $0
Q3 2022

Oct 03, 2022

SELL
$296.48 - $337.87 $14,231 - $16,217
-48 Reduced 1.32%
3,580 $1.16 Million
Q1 2022

Apr 05, 2022

SELL
$234.69 - $291.66 $1.14 Million - $1.42 Million
-4,877 Reduced 57.34%
3,628 $1.04 Million
Q4 2021

Jan 03, 2022

SELL
$224.85 - $279.04 $1.08 Million - $1.34 Million
-4,810 Reduced 36.12%
8,505 $2.35 Million
Q3 2021

Oct 04, 2021

BUY
$221.6 - $272.71 $32,353 - $39,815
146 Added 1.11%
13,315 $3.08 Million
Q2 2021

Jul 06, 2021

SELL
$180.55 - $233.54 $80,525 - $104,158
-446 Reduced 3.28%
13,169 $3.02 Million
Q1 2021

Apr 01, 2021

BUY
$164.32 - $212.72 $39,929 - $51,690
243 Added 1.82%
13,615 $2.54 Million
Q4 2020

Jan 04, 2021

SELL
$130.46 - $172.63 $4,566 - $6,042
-35 Reduced 0.26%
13,372 $2.26 Million
Q3 2020

Oct 02, 2020

SELL
$146.22 - $169.13 $9,650 - $11,162
-66 Reduced 0.49%
13,407 $1.99 Million
Q2 2020

Jul 02, 2020

SELL
$136.42 - $164.18 $954 - $1,149
-7 Reduced 0.05%
13,473 $2.21 Million
Q1 2020

Apr 06, 2020

SELL
$119.05 - $147.35 $26,786 - $33,153
-225 Reduced 1.64%
13,480 $1.87 Million
Q4 2019

Jan 16, 2020

BUY
$106.92 - $132.43 $1.47 Million - $1.81 Million
13,705 New
13,705 $1.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Red Spruce Capital, LLC Portfolio

Follow Red Spruce Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.